Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

Inovio Pharmaceuticals, Inc. (INO)

Surgical & Medical Instruments & Apparatus

https://www.inovio.com

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

6769 MESA RIDGE RD.
SAN DIEGO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/08/1998

Market Cap

205,117,970

Shares Outstanding

272,990,000

Weighted SO

272,986,424

Total Employees

N/A

Upcoming Earnings

08/14/2024

Similar Tickers

NVAX --.--%

VXRT --.--%

ENVB --.--%

CWBR --.--%

OCEA --.--%

HEPA --.--%

ELEV --.--%

AVRO --.--%

Beta

0.8940

Last Div

0.0000

Range

3.84-14.75

Chg

0.1000

Avg Vol

375859

Mkt Cap

205117970

Exch

NASDAQ

Country

US

Phone

267 440 4200

DCF Diff

9.5472

DCF

-1.6965

Div Yield

0.0000

P/S

346.5656

EV Multiple

-1.4595

P/FV

2.2211

Div Yield %

0.0000

P/E

-1.7664

PEG

-0.5748

Payout

0.0000

Current Ratio

4.4531

Quick Ratio

4.4531

Cash Ratio

1.3028

DSO

1093.8209

DIO

0.0000

Op Cycle

1093.8209

DPO

836.5133

CCC

257.3076

Gross Margin

-3.7247

Op Margin

-215.6403

Pretax Margin

-205.5227

Net Margin

-205.5227

Eff Tax Rate

0.0026

ROA

-0.9091

ROE

-1.0893

ROCE

-1.1884

NI/EBT

1.0000

EBT/EBIT

0.9531

EBIT/Rev

-215.6403

Debt Ratio

79.6769

D/E

110.1989

LT Debt/Cap

0.9910

Total Debt/Cap

0.9910

Int Coverage

-870.1754

CF/Debt

-0.0113

Equity Multi

1.3831

Rec Turnover

0.3337

Pay Turnover

0.4363

Inv Turnover

0.0000

FA Turnover

0.0444

Asset Turnover

0.0044

OCF/Share

-4.4153

FCF/Share

-4.4214

Cash/Share

4.0599

OCF/Sales

-202.8953

FCF/OCF

1.0014

CF Coverage

-0.0113

ST Coverage

-51.7167

CapEx Coverage

-719.3586

Div&CapEx Cov

-719.3586

P/BV

2.2211

P/B

2.2211

P/S

346.5656

P/E

-1.7664

P/FCF

-1.7057

P/OCF

-1.7892

P/CF

-1.7892

PEG

-0.5748

P/S

346.5656

EV Multiple

-1.4595

P/FV

2.2211

DPS

0.0000

Latest Headlines (EST)

The Motley Fool Feb 15, 13:15 3 Breakout Growth Stocks You Can Buy and Hold for the Next Decade GlobeNewswire Inc. Feb 06, 05:54 Motwani Jadeja Foundation Enables 10 Indian Leaders to Experience Davos for the First Time GlobeNewswire Inc. Aug 19, 20:43 Toyota Motor (TM) Admits to Mishandling Safety Tests, Faces Securities Class Action – Hagens Berman GlobeNewswire Inc. Aug 13, 23:28 Toyota Motor (TM) Admits to Mishandling Safety Tests, Faces Securities Class Action – Hagens Berman GlobeNewswire Inc. Jul 12, 05:17 Hexagon Purus secures up to CAD 8.5 million in funding from - GlobeNewswire The Motley Fool Jan 15, 09:49 3 Stocks in This $2 Trillion Industry Can Help Make You Rich The Motley Fool Jan 15, 09:49 3 Stocks in This $2 Trillion Industry Can Help Make You Rich The Motley Fool Jan 14, 07:32 4 Top Energy Stocks for 2024 and Beyond The Motley Fool Jan 14, 07:32 4 Top Energy Stocks for 2024 and Beyond Benzinga Nov 27, 13:41 Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session Benzinga Nov 22, 07:32 These 3 Energy Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts The Motley Fool Nov 10, 00:00 Inovio Pharmaceuticals (INO) Q3 2023 Earnings Call Transcript The Motley Fool Nov 10, 00:00 Inovio Pharmaceuticals (INO) Q3 2023 Earnings Call Transcript The Motley Fool Nov 10, 00:00 Inovio Pharmaceuticals (INO) Q3 2023 Earnings Call Transcript The Motley Fool Nov 10, 00:00 Inovio Pharmaceuticals (INO) Q3 2023 Earnings Call Transcript The Motley Fool Nov 10, 00:00 Inovio Pharmaceuticals (INO) Q3 2023 Earnings Call Transcript MarketWatch Nov 06, 14:08 Five potential takeover targets in the oil industry, following deals by Exxon Mobil and Chevron

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.01 09/28/2017 09/21/2017 09/29/2017 10/16/2017
0.01 08/29/2017 08/22/2017 08/31/2017 09/15/2017
0.01 07/27/2017 07/25/2017 07/31/2017 08/15/2017
0.01 06/28/2017 06/23/2017 06/30/2017 07/17/2017